© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Lite Strategy, Inc. (LITS) stock surged +0.70%, trading at $1.44 on NASDAQ, up from the previous close of $1.43. The stock opened at $1.43, fluctuating between $1.37 and $1.53 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 1.43 | 1.53 | 1.37 | 1.44 | 2.26M |
| Sep 24, 2026 | 1.33 | 1.54 | 1.31 | 1.43 | 5.24M |
| Sep 23, 2026 | 1.28 | 1.31 | 1.17 | 1.18 | 584.25K |
| Sep 21, 2026 | 1.20 | 1.33 | 1.08 | 1.28 | 1.61M |
| Sep 18, 2026 | 1.07 | 1.15 | 1.03 | 1.13 | 1.02M |
| Sep 17, 2026 | 1.07 | 1.13 | 1.04 | 1.04 | 904.98K |
| Sep 16, 2026 | 1.07 | 1.07 | 0.99 | 1.02 | 318.23K |
| Sep 15, 2026 | 1.14 | 1.17 | 1.05 | 1.09 | 318.1K |
| Sep 14, 2026 | 1.11 | 1.20 | 1.11 | 1.15 | 329.64K |
| Sep 11, 2026 | 1.06 | 1.12 | 1.06 | 1.11 | 278.1K |
| Sep 10, 2026 | 1.00 | 1.10 | 1.00 | 1.06 | 230.96K |
| Sep 09, 2026 | 1.11 | 1.13 | 1.03 | 1.06 | 487.84K |
| Sep 08, 2026 | 1.14 | 1.15 | 1.09 | 1.10 | 286.75K |
| Sep 04, 2026 | 1.02 | 1.14 | 1.02 | 1.14 | 158.09K |
| Sep 03, 2026 | 1.04 | 1.10 | 1.01 | 1.04 | 2.49M |
| Sep 02, 2026 | 0.98 | 1.06 | 0.98 | 1.04 | 71.06K |
| Sep 01, 2026 | 0.97 | 1.01 | 0.97 | 0.99 | 82.99K |
| Aug 31, 2026 | 0.96 | 1.00 | 0.96 | 0.99 | 106.76K |
| Aug 28, 2026 | 1.00 | 1.02 | 0.97 | 0.98 | 103K |
| Aug 27, 2026 | 1.04 | 1.05 | 1.00 | 1.00 | 190.12K |
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
| Employees | 4 |
| Beta | 0.04 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |